Pharma & Biotech News , from our Global Correspondents
Refine Search
Pharmaceutical
AstraZeneca plans to sign a special investment contract with the Russian government, which should strengthen its position in the Russian market and improve the conditions of doing business in that country. 22 December 2016
Pharmaceutical
Sweeping changes are afoot at India's Health Ministry to encourage innovation in the pharmaceutical sector and to ensure speedier approvals for conducting medical research, reports The Pharma Letter's India correspondent. 21 December 2016
Pharmaceutical
The Russian Federal Antimonopoly Service (FAS) has designed a mechanism for the withdrawal of licenses on the production of drugs in Russia from their rightful owners, according to Igor Artemyev, head of the FAS. 13 December 2016
Pharmaceutical
Global drugmakers operating their plants in Russia have criticized the latest state initiative to introduce new restrictions on the participation of foreign drug manufacturers in tenders for the public procurement of drugs for state needs, reports The Pharma Letter’s local correspondent. 6 December 2016
Pharmaceutical
Russian drugmaker Binnopharm, which is owned by the local financial conglomerate AFK Systema, may become a leading player in the Russian market of over-the-counter (OTC) drugs in the coming years, reports The Pharma Letter’s local correspondent. 6 December 2016
Pharmaceutical
Some 344 fixed dose combination (FDC) medications that have been off chemists' shelves in India for some time now, are to make a reappearance, with the Delhi High Court setting aside the Indian government’s decision to ban the FDC drugs. 5 December 2016
Pharmaceutical
It is likely some readers of this article are of the opinion that Japan is a tough market to crack, says P Reed Maurer, long-time Japan pharma watcher and president of International Alliances Limited in an exclusive article for The Pharma Letter. 28 November 2016
Pharmaceutical
Russian drugmaker Nanolek and Dutch vaccines producer Bilthoven Biologicals, which was acquired by Serum Institute of India in 2012, have officially commissioned a new plant for the production of vaccines in the Russian Kirov region, reports The Pharma Letter’s local correspondent. 25 November 2016
Pharmaceutical
Japan is likely to see more than 20 new drugs from French pharma major Sanofi by 2020, said the newly-appointed Sanofi Japan chief executive Jacques Nathan at a press meeting held in Tokyo earlier this month. 25 November 2016
Pharmaceutical
The Russian government has designed new restrictions for the participation of foreign drugmakers in state tenders for the purchase of drugs for state needs, reports The Pharma Letter’s local correspondent. 25 November 2016
Generics
Even as Astellas Pharma and Pfizer have received the green signal on a supplemental New Drug Application from the US Food and Drug Administration for Xtandi (enzalutamide) to treat advanced prostate cancer, the Indian patent office has denied Xtandi a patent, opening up the market to generic versions of the drug, reports The Pharma Letter’s India correspondent. 23 November 2016
Generics
Russian drugmaker Biocad has announced that it has successfully completed registration of a generic of glatiramer acetate, a drug for the treatment of multiple sclerosis, reports The Pharma Letter’s local correspondent. 14 November 2016
Pharmaceutical
Even as a key regulatory agency that decides the list and prices of essential drugs in India is set to take on a new avatar (form) with the government looking to disband the National Pharmaceutical Pricing Authority (NPPA), US pharma giant Pfizer has received a major fillip in India by securing two Indian process patents related to its blockbuster drug etanercept. 14 November 2016
Pharmaceutical
US drugmaker Abbott (NYSE: ABT) has officially commissioned a new line for the production of gelatine capsules at its Veropharm plant in the Russian city of Belgorod. 4 November 2016
Pharmaceutical
The Russian Ministry of Health has approved the list of vaccines that will be produced in Russia in the coming years, according to recent statements by Veronika Skvortsova, Russia’s Minister of Health, reports The Pharma Letter’s local correspondent. 3 November 2016
Generics
Japanese drugmaker Mitsui & Co is considering expanding into the Russian pharmaceutical market, through the acquisition of a 10% stake in R-Pharm, one of Russia’s largest pharmaceutical producers. 3 November 2016
Biosimilars
Therapeutic proteins (biosimilars) manufactured from natural sources and providing solutions for several unmet clinical needs are the next big thing in India. Adoption, growing investment and deal making in the global arena has got several Indian companies tuning in to biosimilars, reports The Pharma Letter’s India correspondent. 31 October 2016
Pharmaceutical
My knowledge of doctors and hospitals in Japan is above average, having lived here for 46 years while working in the health care industry and receiving medical care, including four operations, says long-time Japanese industry watcher P Reed Maurer, president of International Alliances Limited. 31 October 2016
Biotechnology
The young Chinese venture-capital backed biotech company Ambrx has received some good news recently. 31 October 2016
Pharmaceutical
Even as Sun Pharmaceuticals has entered the vaccines business with an indigenous dengue vaccine candidate for all four serotypes of dengue, more than 34 fresh cases of dengue have been reported from Vadodara in Ahmedabad, Gujarat, India. 21 October 2016
Pharmaceutical
Big pharmas are not deterred by China’s increasingly complex business environment. Instead, they are changing strategies to minimize risks while continuing to benefit from China, said speakers at ChinaTrials held last week in Shanghai. 18 November 2024
Generics
Indian drugmaker Aurobindo Pharma has taken on the might of China in terms of Penicillin G pricing, and is doing so by leveraging a fully integrated production process at its new plant. Anticipating the price erosion of Penicillin G, the company has put up an integrated plant from scratch. 10 November 2024
Generics
Indian markets are abuzz with a singular refrain. Donald Trump's Presidency of the United States is set to open new opportunities for India, especially in the pharmaceutical sector. 8 November 2024
Biotechnology
According to UNICEF's State of the World's Children 2023 report, in Latin America
and the Caribbean, 6.8 million children did not benefit from vaccination during the
time of the pandemic and in the following two years, progress has not been as
expected either. 7 November 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
India's new Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE) scheme is a significant step towards consolidating and advancing the country's biotechnology initiative. 7 October 2024
Pharmaceutical
India is set to complete 50 new greenfield pharma manufacturing plants in the next two years under its Production-linked Incentive (PLI) scheme for pharma and medical devices. 30 September 2024
Generics
The number of clinical trials of new drugs in Russia is steadily declining, which could be mainly related with the overall reduction of investment activities in the local pharmaceutical market, reports The Pharma Letter’s local correspondent. 30 September 2024
Pharmaceutical
Pharmaceutical laboratories, institutions, guilds and medical federations have taken on the task of designing programs to end health illiteracy in order to have informed, educated, knowledgeable and empowered communities where their health and wellbeing are concerned. 19 September 2024
Pharmaceutical
Oligonucleotide therapeutics are rapidly emerging as a promising class of drugs capable of addressing a variety of genetic and complex diseases by targeting RNA sequences.1 16 September 2024
Generics
The protection of intellectual property (IP) rights of foreign pharmaceutical companies in Russia remains complex situation, according to recent statements by Konstantin Panurovsky, legal director of AstraZeneca’s Russian subsidiary, reports The Pharma Letter’s local correspondent. 13 September 2024
Pharmaceutical
The Russian Ministry of Health wants to speed registration of drugs that are not localized in the Russian Federation at the time of the application submitted by domestic pharmaceutical companies, explaining such changes by "unpredictable geopolitical situation," reports The Pharma Letter’s local correspondent. 12 September 2024
Biotechnology
NewCo, a relatively new business model that involves a joint venture (JV) between a biotech and a group of investors to bring the biotech’s promising assets to the global market, is gaining popularity among Chinese biotechs, who traditionally rely on out-licensing deals to capitalize assets, s 11 September 2024
Generics
A significant drop has been noticed in the prices of active pharmaceutical ingredients (APIs), bringing much-needed relief to the pharmaceutical industry and potentially translating to lower drug costs for consumers. 9 September 2024
Biotechnology
Targeted alpha therapy (TAT), or radioligand therapy, is a recent hot area that attracted big pharmas like Bristol Myers Squibb and Novartis. 5 September 2024
Generics
German pharma major Bayer has filed a lawsuit against the Russian drugmaker Promomed to protect the patent rights for Xarelto (rivaroxaban), its treatment for stroke prevention which is the best-selling drug in the Russian market at present, The Pharma Letter’s local correspondent reports. 2 September 2024
Pharmaceutical
Scientists from the Russian Institute of Immunology of the Federal Medical and Biological Agency (FMBA) say they have created the world's first allergy vaccine. 30 August 2024
Generics
In a major crackdown, the Indian government has imposed an immediate ban on 156 fixed-dose combination (FDC) drugs, including commonly used antibiotics, pain relievers,and multivitamins. 27 August 2024
Pharmaceutical
Russia plans to create conditions for a significant increase of domestic production of anti-Rhesus immunoglobulin drugs after a sharp decrease of their imports to the local market this year, reports The Pharma Letter’s local correspondent. 22 August 2024
Generics
One of the largest pharmaceutical production facilities in the Russian North-West region will soon be built in the city of Pushkino by the local drugmaker Active Component enterprise, The Pharma Letter’s local correspondent reports. 14 August 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze